市場調查報告書
商品編碼
1467612
2024-2032 年醫療保健市場 3D 列印材料、技術(液滴沉積、光聚合、雷射光束熔化、電子束熔化、層壓物體製造等)、應用、最終用戶和地區報告3D Printing in Healthcare Market Report by Material,Technology (Droplet Deposition, Photopolymerization, Laser Beam Melting, Electronic Beam Melting, Laminated Object Manufacturing, and Others), Application, End User, and Region 2024-2032 |
IMARC Group年,全球醫療保健3D列印市場規模達30億美元。與影像技術的日益融合、3D 列印公司和醫療機構之間不斷加強的合作、器官和組織列印潛力的不斷成長以及桌面 3D 列印機的便利性是推動市場發展的一些因素。
在醫療保健領域,3D (3D) 列印已成為一種具有多種應用的變革性技術。這項尖端技術透過促進外科切割工具、鑽導板和義肢的開發,正在徹底改變這個領域。此外,它還可以製作針對患者的骨骼、器官和血管的複製品,從而促進精確的手術計劃和培訓。此外,3D 列印在再生醫學和組織工程中發揮重要作用,可以創造活的人體細胞和組織。這項突破為客製化醫療解決方案鋪平了道路,從客製化義肢到針對患者的藥物配方和設備改造。其主要優勢之一在於降低複雜手術過程中的手術風險,最大限度地減少感染的可能性,並限制麻醉暴露的持續時間。這不僅提高了患者的安全,也加快了康復速度。此外,3D 列印有助於節省時間和成本,簡化醫療流程並確保更有效地提供醫療服務。因此,這項技術在全球醫療保健產業中獲得了巨大的關注,為創新和個人化照護提供了前所未有的可能性。正如我們所知,它具有改變醫療保健的潛力,證明了醫療技術的不斷進步。
全球市場主要受到 3D 列印技術不斷進步的推動。與此一致的是,醫療設備和植入物的客製化以及醫學研究的快速原型設計正在為市場做出巨大貢獻。此外,複雜解剖模型的經濟高效生產正在對市場產生積極影響。除此之外,對患者專用手術導板的需求不斷成長以及慢性病盛行率的不斷上升正在催化市場。此外,老年人口的不斷增加以及藥物開發和測試的加速正在推動市場的發展。此外,加強手術規劃和培訓正在增強市場。義肢和矯形外科應用的增加以及生物相容性材料產量的增加正在推動市場的發展。此外,對醫療 3D 列印的監管支援以及醫療保健專業人員日益增強的意識也為市場提供了推動力。
對再生藥物、幹細胞解決方案和癌症治療的需求不斷增加
對再生藥物、幹細胞解決方案和癌症治療的需求不斷成長,正在提振市場。再生醫學依賴精確的組織工程和器官複製,而 3D 列印在這方面表現出色。使用生物相容性材料創建患者特異性結構的能力與再生醫學的目標完美契合,為需要組織替換或再生的人帶來了希望。此外,通常用於個人化治療方法的幹細胞解決方案受益於 3D 列印在創建支持細胞生長和分化的客製化支架和結構方面的精確性。此外,癌症療法的開發擴大涉及模擬腫瘤環境的 3D 列印模型。這些模型有助於藥物測試,最終導致更有效和客製化的癌症治療。
研發 (R&D) 活動投資不斷增加
不斷增加的研發 (R&D) 投資創造了積極的市場前景。研發投資通常會導致尖端技術和創新的發展,從而徹底改變產業。它使公司能夠創造新的和改進的產品,保持競爭力,並滿足不斷變化的客戶需求。研究工作可以提高生產流程的效率,降低成本和資源消耗。它可以幫助公司開拓新市場、擴大產品範圍並涵蓋更廣泛的客戶群。它還可以促進環保技術和實踐的發展,解決環境問題。研發資金推動醫療保健領域的醫學發現,從而帶來新的治療方法、藥物和療法。強大的研發生態系統可以透過創造就業、促進創新和吸引投資來刺激經濟成長。
擴大醫藥應用
3D 列印在製藥領域的不斷擴大應用正在推動醫療保健市場的顯著成長。這項變革因素透過允許藥物的精確定製而徹底改變了藥物開發和交付。透過 3D 列印,可以定製藥物以滿足患者的個別需求,從而實現更有效的治療並改善患者的治療效果。此外,3D列印有助於創建複雜的藥物輸送系統,實現控制釋放並提高藥物療效。該技術能夠快速製作新藥物配方原型,從而加速藥物開發,並減少時間和成本。此外,透過 3D 列印,兒科藥物和罕見疾病專用藥物的生產變得更加可行且更具成本效益。隨著監管機構適應這些創新,醫療保健產業正在見證藥品生產和患者護理的根本性轉變,推動市場大幅成長,並有望在未來提供更個人化和高效的醫療保健解決方案。
The global 3D printing in healthcare market size reached US$ 3.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.4 Billion by 2032, exhibiting a growth rate (CAGR) of 13.2% during 2024-2032. The increasing integration with imaging technologies, the rising collaborations between 3D printing companies and healthcare institutions, the growing potential for organ and tissue printing, and the easy accessibility of desktop 3D printers are some of the factors propelling the market.
In healthcare, three-dimensional (3D) printing has emerged as a transformative technology with diverse applications. This cutting-edge technology is revolutionizing the field by enabling the development of surgical cutting tools, drill guides, and prosthetics. Additionally, it can craft patient-specific replicas of bones, organs, and blood vessels, facilitating precise surgical planning and training. Moreover, 3D printing is instrumental in regenerative medicine and tissue engineering, where it can create living human cells and tissues. This breakthrough paves the way for customized medical solutions, from tailored prosthetics to patient-specific drug formulations and equipment adaptations. One of its key advantages lies in reducing operative risks during intricate procedures, minimizing the likelihood of infections, and limiting the duration of anesthesia exposure. This not only enhances patient safety but also expedites recovery. Furthermore, 3D printing contributes to time and cost savings, streamlining the healthcare process and ensuring more efficient delivery of medical services. As a result, this technology is gaining remarkable traction across the global healthcare industry, offering unprecedented possibilities for innovation and personalized care. Its potential to transform healthcare as we know it is a testament to the ongoing advancements in medical technology.
The global market is majorly driven by the increasing advancements in 3D printing technology. In line with this, the customization of medical devices and implants and the rapid prototyping for medical research are significantly contributing to the market. Furthermore, the cost-effective production of complex anatomical models is positively influencing the market. Apart from this, the rising demand for patient-specific surgical guides and the growing prevalence of chronic diseases are catalyzing the market. Moreover, the escalating elderly population and the accelerating drug development and testing are propelling the market. Besides, enhanced surgical planning and training are strengthening the market. The increasing prosthetics and orthopedic applications and the rising production of biocompatible materials are fueling the market. Additionally, the regulatory support for medical 3D printing and the growing awareness among healthcare professionals are providing a boost to the market.
Increasing need for regenerative medicines, stem cell solutions, and cancer therapeutics
The increasing need for regenerative medicines, stem cell solutions, and cancer therapeutics is bolstering the market. Regenerative medicine relies on precise tissue engineering and organ replication, where 3D printing excels. The ability to create patient-specific constructs with biocompatible materials aligns perfectly with regenerative medicine's goals, offering hope for those in need of tissue replacement or regeneration. Furthermore, stem cell solutions, often used for personalized treatment approaches, benefit from 3D printing's precision in creating custom scaffolds and structures that support cell growth and differentiation. Moreover, the development of cancer therapeutics increasingly involves 3D-printed models to mimic tumor environments. These models aid drug testing, ultimately leading to more effective and tailored cancer treatments.
Rising investments in research and development (R&D) activities
Rising research and development (R&D) investments create a positive market outlook. Investment in R&D often results in the development of cutting-edge technologies and innovations that can revolutionize industries. It allows companies to create new and improved products, stay competitive, and meet evolving customer demands. Research efforts can lead to more efficient production processes, reducing costs and resource consumption. It can help companies explore new markets, expand their product offerings, and reach a broader customer base. It can also lead to the development of eco-friendly technologies and practices, addressing environmental concerns. R&D funding drives medical discoveries in healthcare, leading to new treatments, drugs, and therapies. A robust R&D ecosystem can stimulate economic growth by creating jobs, fostering innovation, and attracting investment.
Expanding pharmaceutical applications
The expanding pharmaceutical applications of 3D printing are propelling significant growth in the healthcare market. This transformative factor is revolutionizing drug development and delivery by allowing for the precise customization of pharmaceuticals. With 3D printing, medications can be tailored to meet individual patient needs, resulting in more effective treatments and enhanced patient outcomes. Moreover, 3D printing facilitates the creation of complex drug delivery systems, enabling controlled release and improved drug efficacy. The technology's ability to rapidly prototype new drug formulations accelerates drug development, reducing time and costs. Additionally, the production of pediatric medications and specialized drugs for rare diseases is made more feasible and cost-effective through 3D printing. As regulatory bodies adapt to accommodate these innovations, the healthcare industry is witnessing a fundamental shift in pharmaceutical production and patient care, driving substantial market growth and promising a future of more personalized and efficient healthcare solutions.
IMARC Group provides an analysis of the key trends in each segment of the global 3D printing in healthcare market report, along with forecasts at the global, regional and country levels for 2024-2032. Our report has categorized the market based on material, technology, application, and end user.
Polymer
Metals
Ceramic
Organic
Polymer dominates the market
The report has provided a detailed breakup and analysis of the market based on the material. This includes polymer, metals, ceramic, and organic. According to the report, polymer represented the largest segment.
Polymer-based 3D printing is instrumental in creating various medical devices, prosthetics, and customized implants. Biocompatible polymers like PLA and PEEK are widely used in creating patient-specific anatomical models and dental applications. Moreover, they are suitable materials for cost-effective prosthetic limbs and orthopedic implants, enhancing patient mobility and comfort.
On the other hand, metal 3D printing is revolutionizing the production of intricate and durable medical components. Titanium and stainless steel alloys are commonly employed in manufacturing orthopedic implants, cranial implants, and dental prosthetics. These metals offer exceptional strength and biocompatibility, ensuring the longevity and reliability of implanted devices. Additionally, metal 3D printing's precision allows for intricate lattice structures that promote osseointegration, enabling faster healing and improved patient outcomes.
Droplet Deposition
Fused Filament Fabrication (FFF) Technology
Low-temperature Deposition Manufacturing (LDM)
Multiphase Jet Solidification (MJS)
Photopolymerization
Stereolithography (SLA)
Continuous Liquid Interface Production (CLIP)
Two-photon Polymerization (2PP)
Laser Beam Melting
Selective Laser Sintering (SLS)
Selective Laser Melting (SLM)
Direct Metal Laser Sintering (DMLS)
Electronic Beam Melting (EBM)
Laminated Object Manufacturing
Others
Droplet deposition dominates the market
The report has provided a detailed breakup and analysis of the market based on the technology. This includes droplet deposition (fused filament fabrication (FFF) technology, low-temperature deposition manufacturing (LDM), multiphase jet solidification (MJS)), photopolymerization (stereolithography (SLA), continuous liquid interface production (CLIP), two-photon polymerization (2PP)), laser beam melting (selective laser sintering (SLS), selective laser melting (SLM), direct metal laser sintering (DMLS)), electronic beam melting (EBM), laminated object manufacturing, and others. According to the report, droplet deposition represented the largest segment.
Droplet Deposition technology, also known as Fused Deposition Modeling (FDM), is cost-effective and widely used for producing patient-specific anatomical models, custom prosthetics, and orthopedic implants. It offers versatility and accessibility, making it suitable for various healthcare applications, including educational purposes.
On the other hand, utilizing photoreactive polymers, photopolymerization, exemplified by stereolithography (SLA) and Digital Light Processing (DLP), excels in creating highly detailed and intricate medical models and dental devices. It enables the production of accurate prototypes, dental crowns, and surgical guides, supporting precise and personalized healthcare solutions.
Moreover, laser-based technologies like Selective Laser Sintering (SLS) and Direct Metal Laser Sintering (DMLS) are vital for manufacturing complex metal components such as orthopedic implants, prosthetics, and dental restorations. The exceptional accuracy and material strength provided by laser beam melting is essential for critical medical applications, ensuring durability and biocompatibility.
External Wearable Devices
Hearing Aids
Prosthesis and Orthotics
Dental Products
Clinical Study Devices
Drug Testing
Anatomical Models
Implants
Surgical Guides
Cranio-maxillofacial Implants
Orthopedic Implants
Tissue Engineering
External Wearable Devices dominates the market
The report has provided a detailed breakup and analysis of the market based on the application. This includes external wearable devices (hearing aids, prosthesis and orthotics, dental products), clinical study devices (drug testing and anatomical models), implants (surgical guides, cranio-maxillofacial implants, and orthopedic implants), and tissue engineering. According to the report, external wearable devices represented the largest segment.
3D printing technology facilitates the production of custom-fit external wearable devices such as prosthetic limbs, orthopedic braces, and hearing aids. These personalized devices enhance patient comfort, mobility, and quality of life, driving growth in this segment.
On the contrary, 3D printing creates patient-specific models, surgical guides, and anatomical replicas in medical research and clinical trials. These devices are instrumental in enhancing surgical training, medical education, and preoperative planning, thus contributing to the growth of this segment.
Moreover, the production of implants, including orthopedic, dental, and cranial implants, is a critical application of 3D printing in healthcare. These patient-specific implants offer improved functionality, durability, and biocompatibility, driving significant growth in the market.
Medical and Surgical Centers
Pharmaceutical and Biotechnology Companies
Academic Institutions
Medical and surgical centers dominates the market
The report has provided a detailed breakup and analysis of the market based on the end user. This includes medical and surgical centers, pharmaceutical and biotechnology companies, and academic institutions. According to the report, medical and surgical centers represented the largest segment.
Medical and surgical centers include hospitals, clinics, and specialized healthcare facilities. These institutions widely utilize 3D printing for applications such as patient-specific anatomical models, surgical guides, custom prosthetics, and orthopedic implants. The technology empowers healthcare providers with tools for precise diagnosis, treatment planning, and patient-specific interventions, enhancing overall patient care and surgical outcomes. The growing adoption of 3D printing in medical and surgical centers drives market growth by improving healthcare delivery.
Furthermore, the pharmaceutical and biotechnology sector leverages 3D printing for drug development, personalized medicine, and drug delivery systems. 3D-printed pills, tablets, and drug-loaded implants enable precise dosing, improved drug release profiles, and customized therapies. This segment fosters market growth by advancing drug development processes and enhancing the efficacy and safety of pharmaceutical products.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance, accounting for the largest market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America, encompassing the United States and Canada, is a significant driver of growth in 3D printing in healthcare market due to several key factors. It is a hub for technological advancements and innovation, fostering the development and adoption of 3D printing in healthcare applications. The region boasts advanced healthcare facilities and research institutions that actively utilize 3D printing for patient-specific models, surgical planning, and medical device production. Regulatory bodies in North America have been receptive to 3D printing technologies in healthcare, expediting approvals for medical devices and implants.
Ongoing investment in research and development activities fuels continuous innovation and growth in 3D printing applications, benefiting both the medical and pharmaceutical sectors. The region is home to leading 3D printing companies and healthcare providers that drive market growth through collaborations and investments in cutting-edge technologies. Furthermore, patients increasingly seek personalized healthcare solutions, escalating the adoption of 3D printing for customized implants, prosthetics, and medical models.
Top companies are strengthening the market growth through their innovative approaches and unwavering commitment to advancing medical technology. These industry leaders are contributing to growth in several key ways. They are at the forefront of research and development, investing heavily in cutting-edge technologies that enhance the capabilities of 3D printing in healthcare. These innovations expand the scope of applications, from patient-specific implants to drug delivery systems. Top companies actively collaborate with healthcare institutions and research organizations to drive progress. These collaborations result in groundbreaking solutions and foster a deeper understanding of 3D printing's potential in medicine. They work closely with regulatory authorities to ensure compliance with evolving healthcare standards, facilitating the adoption of 3D-printed medical devices and pharmaceuticals. These companies invest in educational initiatives to train healthcare professionals to use 3D printing technology effectively. They contribute to global awareness, demonstrating the transformative impact of 3D printing in healthcare through case studies and success stories. Their dedication to pushing the boundaries of what's possible in the medical field ensures the continued growth and evolution of 3D printing in healthcare market.
The report has provided a comprehensive analysis of the competitive landscape of 3D printing in healthcare market. Detailed profiles of all major companies have also been provided.
3D Systems Inc.
Desktop Metal Inc.
EOS GmbH
Formlabs
Materialise NV
Organovo Holding Inc.
Oxford Performance Materials Inc.
Prodways Tech
Proto Labs Inc.
Renishaw plc
SLM Solutions Group AG
Stratasys Ltd
In August 2023, 3D Systems, a prominent player in additive manufacturing solutions, and Theradaptive, a biopharmaceutical innovator specializing in targeted regenerative therapies, unveiled a commercial agreement. This partnership designates 3D Systems as the exclusive 3D printing collaborator for Theradaptive. Together, they are poised to introduce an innovative approach to stimulate bone and tissue growth.
In July 2023, Desktop Health forged a strategic partnership with Carbon to introduce the Flexcera Family Resins to the Carbon Digital Manufacturing Platform. This collaboration represents a significant development in digital manufacturing and dental technology.
In June 2023, EOS GmbH partnered with Tecomet, Inc., Precision ADM, and OIC to provide end-to-end medical device additive manufacturing solutions.